High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study

Conditions

• Cerebral Atherosclerosis

Interventions

• DRUG: Evolocumab 140 MG/ML
• DRUG: Intensive statin treatment

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology